04.07.15
Grand River Aseptic Manufacturing (GRAM) has appointed current president Tom Ross to the position of chief executive officer of the company. Tom first joined Grand River in January 2013 serving as an advisor to the company and shortly thereafter was named president in August 2013.
Before coming to Grand River, Mr. Ross spent a good part of his career at Perrigo, a large generic pharmaceutical manufacturer based in Michigan. He quickly rose through the ranks and became the top financial officer on the executive team. While serving in executive roles at Perrigo, the company grew from $300 million to $1 billion. Mr. Ross eventually left Perrigo to start two successful companies of his own.
Jerry Arthur, chairman of GRAM said, “Tom’s vision is that the company be a high growth, industry leader in life sciences. With his leadership, intellect and discipline, GRAM is well on its way to making this vision a reality. In his short time at GRAM, Mr. Ross has been able to secure $10 million in investment, opened a finishing facility, and grow the company from 25 employees to over 70 today. This year will be a milestone year for GRAM as the company anticipates explosive growth in 2015.”
“It is an honor to lead a team of highly accomplished and skilled associates at GRAM,” said Mr. Ross. “We are very proud that GRAM was formed in Dec. 2010 and in just over four years, we have become FDA approved as a parenteral sterile injectable pharmaceutical company and have secured several large new customers. Our customers depend on GRAM’s adherence to the strictest quality standards to produce safe and effective pharmaceuticals. GRAM’s team continues to expand and we look forward to a very bright future with exceptional growth.”
Before coming to Grand River, Mr. Ross spent a good part of his career at Perrigo, a large generic pharmaceutical manufacturer based in Michigan. He quickly rose through the ranks and became the top financial officer on the executive team. While serving in executive roles at Perrigo, the company grew from $300 million to $1 billion. Mr. Ross eventually left Perrigo to start two successful companies of his own.
Jerry Arthur, chairman of GRAM said, “Tom’s vision is that the company be a high growth, industry leader in life sciences. With his leadership, intellect and discipline, GRAM is well on its way to making this vision a reality. In his short time at GRAM, Mr. Ross has been able to secure $10 million in investment, opened a finishing facility, and grow the company from 25 employees to over 70 today. This year will be a milestone year for GRAM as the company anticipates explosive growth in 2015.”
“It is an honor to lead a team of highly accomplished and skilled associates at GRAM,” said Mr. Ross. “We are very proud that GRAM was formed in Dec. 2010 and in just over four years, we have become FDA approved as a parenteral sterile injectable pharmaceutical company and have secured several large new customers. Our customers depend on GRAM’s adherence to the strictest quality standards to produce safe and effective pharmaceuticals. GRAM’s team continues to expand and we look forward to a very bright future with exceptional growth.”